Catheter Precision (NYSEAMERICAN:VTAK) Stock Scheduled to Reverse Split on Monday, October 5th

Shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAK) are set to reverse split on Monday, October 5th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 4th.

Catheter Precision Price Performance

Shares of NYSEAMERICAN VTAK opened at $0.15 on Thursday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.18 and a current ratio of 0.19. Catheter Precision has a one year low of $0.13 and a one year high of $3.20. The firm has a market capitalization of $2.16 million, a P/E ratio of -0.02 and a beta of -1.03. The company’s fifty day moving average is $0.22 and its two-hundred day moving average is $0.69.

Catheter Precision (NYSEAMERICAN:VTAK) last posted its quarterly earnings results on Friday, August 14th. The company reported ($0.92) earnings per share for the quarter, topping analysts’ consensus estimates of ($19.00) by $18.08. Catheter Precision had a negative net margin of 656.03% and a negative return on equity of 37.53%. The business had revenue of $1.02 million for the quarter, compared to analysts’ expectations of $2.00 million.

About Catheter Precision

Catheter Precision, Inc is a medical device company focused on developing technologies for electrophysiology procedures used to diagnose and treat cardiac arrhythmias. Its products are designed to support physicians during catheter-based cardiac procedures, particularly those involving ventricular arrhythmias.

The company’s portfolio includes the VIVO system, a noninvasive cardiac mapping platform intended to help physicians identify the origin of ventricular arrhythmias and plan catheter ablation procedures.